Emmessar Biotech & Nutrition24.50
+0.73 (+3.07%)

Emmessar Biotech & Nutrition Share Price

24.50+0.73 (+3.07%)
-30.34% past 1 Year

Corporate filings & documents

Announcements

Please refer attachment
2 weeks ago
Please refer attachment
2 weeks ago
Please refer attachment
2 weeks ago
Please refer attachment
2 weeks ago
Please refer attachment
2 weeks ago
Please refer attachment
2 weeks ago
Please refer attachment
2 weeks ago
Please refer attachment
2 weeks ago
Please refer attachment
2 weeks ago
Please refer attachment
2 weeks ago
Please refer attachment
4 weeks ago
Please refer attachment
4 weeks ago
Please refer attachment
1 month ago
Please refer attachment
1 month ago
Please refer attachement
1 month ago
Please refer attachement
1 month ago
Please refer attachement
1 month ago
Please refer attachement
1 month ago
Emmessar Biotech & Nutrition Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 inter alia to consider and approve please refer attachment
1 month ago
Emmessar Biotech & Nutrition Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 inter alia to consider and approve please refer attachment
1 month ago
please refer attachment
1 month ago
please refer attachment
1 month ago
Please refer attachment
2 months ago
please refer attachment
3 months ago
please refer attachment
3 months ago
Please refer attachment
4 months ago
please refer attachment
4 months ago
please refer attachment
4 months ago
please refer attachement
4 months ago
please refer attachement
4 months ago
please refer attachment
4 months ago
please refer attachment
4 months ago
Emmessar Biotech & Nutrition Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 inter alia to consider and approve please refer attachement
4 months ago
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Emmessar Biotech & Nutrition Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24110MH1992PLC065942</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Priyanka Sharma <br/> Designation: Company Secretary <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Jeyavel Nadar <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 08/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
5 months ago
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Emmessar Biotech & Nutrition Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24110MH1992PLC065942</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Priyanka Sharma <br/> Designation: Company Secretary <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Jeyavel Nadar <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 08/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
5 months ago
Please refer attachments
5 months ago
Please refer attachment
5 months ago
Please refer attachment
5 months ago
Please refer attachment
6 months ago
Please refer attachment
6 months ago
Please refer attachment
7 months ago
Please refer attachment
7 months ago
Refer attachment
7 months ago
Emmessar Biotech & Nutrition Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve Please refer attachment
7 months ago
Please refer attachment
8 months ago
Refer attachment
9 months ago
Please refer attachment
10 months ago
Please refer attachment
10 months ago
Please refer attachment
10 months ago
Emmessar Biotech & Nutrition Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 inter alia to consider and approve please refer attachment
10 months ago

Concalls & investor presentations

Empty box

No presentations found

Emmessar Biotech & Nutrition Ltd Share Price Today

The Emmessar Biotech & Nutrition Ltd share price today is ₹24.75. During the trading session, the Emmessar Biotech & Nutrition Ltd share price opened at ₹23.84 and recorded an intraday high of ₹24.77 and a low of ₹23.31. Last closing price was ₹23.77. Over the past 52 weeks, the Emmessar Biotech & Nutrition Ltd share price has ranged between ₹18.42 and ₹42.75. The current Emmessar Biotech & Nutrition Ltd stock price reflects real-time market activity based on executed trades on the exchange.